Humira (Adalimumab): Targeted Immunomodulation for Autoimmune Disease Management – Clinical Evidence Review

1. Introduction: What is Humira? Its Role in Modern Medicine Look, I’ve been prescribing biologics for nearly two decades now, and Humira’s probably the one I’ve reached for most often. It’s not the newest kid on the block anymore—we’ve got JAK inhibitors, IL-17 blockers, all sorts of fancy stuff—but there’s a reason adalimumab still dominates the market. It works, it’s predictable, and we know its quirks. Humira is a fully human monoclonal antibody targeting tumor necrosis factor-alpha (TNF-α).